Modeling disease trajectory in Duchenne muscular dystrophy.
Adolescent
Adrenal Cortex Hormones
/ metabolism
Biomarkers
/ analysis
Child
Child, Preschool
Disease Progression
Female
Humans
Leg
/ pathology
Magnetic Resonance Imaging
/ methods
Magnetic Resonance Spectroscopy
/ methods
Male
Muscle, Skeletal
/ drug effects
Muscular Dystrophy, Duchenne
/ diagnosis
Walking
/ physiology
Journal
Neurology
ISSN: 1526-632X
Titre abrégé: Neurology
Pays: United States
ID NLM: 0401060
Informations de publication
Date de publication:
14 04 2020
14 04 2020
Historique:
received:
02
07
2019
accepted:
17
10
2019
pubmed:
19
3
2020
medline:
14
8
2020
entrez:
19
3
2020
Statut:
ppublish
Résumé
To quantify disease progression in individuals with Duchenne muscular dystrophy (DMD) using magnetic resonance biomarkers of leg muscles. MRI and magnetic resonance spectroscopy (MRS) biomarkers were acquired from 104 participants with DMD and 51 healthy controls using a prospective observational study design with patients with DMD followed up yearly for up to 6 years. Fat fractions (FFs) in vastus lateralis and soleus muscles were determined with MRS FF and MRI qT MRS FF and MRI qT NCT01484678.
Identifiants
pubmed: 32184340
pii: WNL.0000000000009244
doi: 10.1212/WNL.0000000000009244
pmc: PMC7251517
doi:
Substances chimiques
Adrenal Cortex Hormones
0
Biomarkers
0
Banques de données
ClinicalTrials.gov
['NCT01484678']
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1622-e1633Subventions
Organisme : NIAMS NIH HHS
ID : R01 AR065943
Pays : United States
Organisme : NIH HHS
ID : S10 OD021701
Pays : United States
Organisme : NIH HHS
ID : S10 OD018224
Pays : United States
Organisme : NIAMS NIH HHS
ID : U54 AR052646
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01 AR056973
Pays : United States
Organisme : NIDA NIH HHS
ID : F30 DA033094
Pays : United States
Organisme : NIMH NIH HHS
ID : R25 MH101076
Pays : United States
Organisme : NHLBI NIH HHS
ID : T32 HL134621
Pays : United States
Informations de copyright
© 2020 American Academy of Neurology.
Références
Lancet. 2002 Feb 23;359(9307):687-95
pubmed: 11879882
Pflugers Arch. 1974 Apr 22;348(3):247-55
pubmed: 4275915
Lancet Neurol. 2016 Jan;15(1):26-8
pubmed: 26549781
PLoS One. 2018 Mar 19;13(3):e0194283
pubmed: 29554116
Neuromuscul Disord. 2014 Jun;24(6):482-91
pubmed: 24780148
Neurology. 2016 Nov 15;87(20):2123-2131
pubmed: 27566742
Cell. 1987 Dec 24;51(6):919-28
pubmed: 3319190
J Neurol. 2013 Apr;260(4):969-74
pubmed: 23138982
Dev Med Child Neurol. 2010 Jan;52(1):60-5
pubmed: 19453691
J Cell Biol. 2013 May 13;201(4):499-510
pubmed: 23671309
Radiology. 2013 Oct;269(1):198-207
pubmed: 23696684
Lancet Neurol. 2016 Jul;15(8):882-890
pubmed: 27302365
Magn Reson Med. 2014 Jul;72(1):8-19
pubmed: 24006208
AJR Am J Roentgenol. 2015 Aug;205(2):W216-23
pubmed: 26204310
Magn Reson Med. 1998 Jan;39(1):53-60
pubmed: 9438437
Dis Model Mech. 2014 Aug;7(8):997-1004
pubmed: 24906372
Handb Clin Neurol. 2016;136:827-42
pubmed: 27430444
Lancet. 2018 Feb 3;391(10119):451-461
pubmed: 29174484
Neuromuscul Disord. 2002 Dec;12(10):917-25
pubmed: 12467746
Curr Opin Neurol. 1997 Apr;10(2):168-75
pubmed: 9146999
Magn Reson Med. 1989 Jan;9(1):126-31
pubmed: 2540394
Curr Opin Pharmacol. 2017 Jun;34:36-48
pubmed: 28486179
Neurology. 1991 Dec;41(12):1874-7
pubmed: 1745340
Cell. 1988 Feb 26;52(4):503-13
pubmed: 3342447
PLoS One. 2016 Mar 14;11(3):e0150818
pubmed: 26974331
Neurology. 2014 Sep 9;83(11):974-80
pubmed: 25098537
Phys Med Rehabil Clin N Am. 2012 Feb;23(1):1-10, ix
pubmed: 22239869
Cell Death Differ. 2017 Feb;24(2):330-342
pubmed: 27834955
Pediatr Neurol. 2008 Mar;38(3):200-6
pubmed: 18279756
Nat Commun. 2018 Sep 7;9(1):3655
pubmed: 30194302
Eur J Paediatr Neurol. 2002;6(6):305-7
pubmed: 12401454
Neuromuscul Disord. 2018 Aug;28(8):690-701
pubmed: 30033203
Ann Neurol. 2016 Apr;79(4):535-47
pubmed: 26891991